„Checkpoint“
Suchergebnisse
5.704 Treffer
-
Integrating S-phase checkpoint signaling with trans-lesion synthesis of bulky DNA adducts
-
Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy
-
A chemical inhibitor of Apaf-1 exerts mitochondrioprotective functions and interferes with the intra-S-phase DNA damage checkpoint
-
Phytochrome-induced expression of lig1, a homologue of the fission yeast cell-cycle checkpoint gene hus1, is associated with the developmental switch in Physarum polycephalum plasmodia
-
Cut5 is a component of the UV-responsive DNA damage checkpoint in fission yeast
-
Molecular analysis of hus1 +, a fission yeast gene required for S-M and DNA damage checkpoints
-
Characterisation of the Schizosaccharomyces pombe rad4/cut5 mutant phenotypes: dissection of DNA replication and G2 checkpoint control function
-
Analyse der Expression der co-inhibitorischen Immun-Checkpoints BTLA und LAG-3 in Blut- und Gewebeproben von Patienten mit Plattenepithelkarzinom der Mundhöhle
-
Tissue and cellular mechanisms regulating T-cell exhaustion and the response to checkpoint immunotherapy
-
Persistent immune-related adverse events after cessation of checkpoint inhibitor therapy: Prevalence and impact on patients’ health-related quality of life
-
Bacterial-Derived Metabolites in the Context of Immune Checkpoint Inhibitor Cancer Therapy
-
Untersuchung des solublen Programmed Cell Death Ligand 1 (sPD-L1) Plasmaspiegels bei Patienten mit paroxysmaler nächtlicher Hämoglobinurie und der Programmed Cell Death Ligand 1 (PD-L1) Expression bei in vitro Komplementaktivierung
-
Differential expression of CSCs biomarkers in renal cell carcinoma stem cells after a combined treatment with phytochemicals and immune checkpoint inhibitors
-
Die Rolle von S100A8/A9 und neutrophilen Granulozyten im Serum sowie deren Wirkung in der Tumor-Mikroumgebung beim malignen Melanom
-
Evaluation of a single radiotherapy fraction, local anti-CD40 antibodies delivered via immunogenic biomaterials, and immune checkpoint inhibitors to optimize abscopal responses in preclinical models of prostate cancer
-
Identification and Characterisation of Novel Mechanisms Regulating TNF-Induced Cell Death
-
The role of tumor cell-intrinsic STING signaling in antitumor immunity and immune checkpoint inhibitor therapy responsiveness
-
Expression von PD-L1 und FGFR1-4 beim anaplastischen und gering differenzierten Schilddrüsenkarzinom - Evaluation als präklinische diagnostische Marker
-
Die Bedeutung von Immun-Checkpoint-Molekülen für die Immunantwort des Neugeborenen
-
Transcriptomic characterization and improvement of immunotherapy in Merkel cell carcinoma